These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19036909)

  • 21. Models for the analysis of C-reactive protein in statin trials.
    Southworth H; Dane A
    Pharm Stat; 2009; 8(2):87-97. PubMed ID: 18481276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of statistical methods for analysis of clustered binary observations.
    Heo M; Leon AC
    Stat Med; 2005 Mar; 24(6):911-23. PubMed ID: 15558576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regularized estimation in the accelerated failure time model with high-dimensional covariates.
    Huang J; Ma S; Xie H
    Biometrics; 2006 Sep; 62(3):813-20. PubMed ID: 16984324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of raw mean differences.
    Bond CF; Wiitala WL; Richard FD
    Psychol Methods; 2003 Dec; 8(4):406-18. PubMed ID: 14664679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjusting for differential proportions of second-line treatment in cancer clinical trials. Part I: structural nested models and marginal structural models to test and estimate treatment arm effects.
    Yamaguchi T; Ohashi Y
    Stat Med; 2004 Jul; 23(13):1991-2003. PubMed ID: 15211598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Test homogeneity of risk difference across subgroups in clinical trials.
    Zhang L; Yang H; Cho I
    J Biopharm Stat; 2009; 19(1):67-76. PubMed ID: 19127467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maximum likelihood estimation in survival studies under progressive interval censoring with random removals.
    Xiang L; Tse SK
    J Biopharm Stat; 2005; 15(6):981-91. PubMed ID: 16279356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of an outcome using trajectories estimated from a linear mixed model.
    Maruyama N; Takahashi F; Takeuchi M
    J Biopharm Stat; 2009 Sep; 19(5):779-90. PubMed ID: 20183443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rate estimation for a simple movement model.
    Silverman E; Kot M
    Bull Math Biol; 2000 Mar; 62(2):351-75. PubMed ID: 10824434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving the estimation of change from baseline in a continuous outcome measure in the clinical trial setting.
    Mayer-Hamblett N; Kronmal RA
    Contemp Clin Trials; 2005 Feb; 26(1):2-16. PubMed ID: 15837448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stratified tests, stratified slopes, and random effects models for clinical trials with missing data.
    Dawson JD; Han SH
    J Biopharm Stat; 2000 Nov; 10(4):447-55. PubMed ID: 11104386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Model misspecification sensitivity analysis in estimating causal effects of interventions with non-compliance.
    Jo B
    Stat Med; 2002 Nov; 21(21):3161-81. PubMed ID: 12375297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mediation and moderation of treatment effects in randomised controlled trials of complex interventions.
    Emsley R; Dunn G; White IR
    Stat Methods Med Res; 2010 Jun; 19(3):237-70. PubMed ID: 19608601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Power comparison of robust approximate and non-parametric tests for the analysis of cross-over trials.
    Correa JA; Bellavance F
    Stat Med; 2001 Apr; 20(8):1185-96. PubMed ID: 11304735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On responder analyses when a continuous variable is dichotomized and measurement error is present.
    Kunz M
    Biom J; 2011 Feb; 53(1):137-55. PubMed ID: 21259314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating linear regression models in the presence of a censored independent variable.
    Austin PC; Hoch JS
    Stat Med; 2004 Feb; 23(3):411-29. PubMed ID: 14748036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An introduction to instrumental variables--part 2: Mendelian randomisation.
    Bennett DA
    Neuroepidemiology; 2010; 35(4):307-10. PubMed ID: 21042034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intention-to-treat analyses for incomplete repeated measures data.
    Hogan JW; Laird NM
    Biometrics; 1996 Sep; 52(3):1002-17. PubMed ID: 8805765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple polyexponentials and quasipolynomials as empirical nonlinear regression models: a case study with HIV viral load data.
    Huson LW; Chung J; Salgo M
    J Biopharm Stat; 2006; 16(2):165-79. PubMed ID: 16584065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.